The RAS/MAPK signaling pathway also plays an important role in gliomagenesis, and the NF1 gene, which is a negative regulator of the RAS oncogene, is most commonly affected in adult-type gliomas [16,59,62]. The gene discussed is NF1; the disease is central nervous system cancer.